125 related articles for article (PubMed ID: 29467488)
1. ANP32A regulates histone H3 acetylation and promotes leukemogenesis.
Yang X; Lu B; Sun X; Han C; Fu C; Xu K; Wang M; Li D; Chen Z; Opal P; Wen Q; Crispino JD; Wang QF; Huang Z
Leukemia; 2018 Jul; 32(7):1587-1597. PubMed ID: 29467488
[TBL] [Abstract][Full Text] [Related]
2. Acidic leucine-rich nuclear phosphoprotein-32A expression contributes to adverse outcome in acute myeloid leukemia.
Huang S; Huang Z; Ma C; Luo L; Li YF; Wu YL; Ren Y; Feng C
Ann Transl Med; 2020 Mar; 8(6):345. PubMed ID: 32355789
[TBL] [Abstract][Full Text] [Related]
3. AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation.
Wei R; Zhu Y; Zhang Y; Zhao W; Yu X; Wang L; Gu C; Gu X; Yang Y
Cancer Commun (Lond); 2022 Nov; 42(11):1185-1206. PubMed ID: 36042007
[TBL] [Abstract][Full Text] [Related]
4. Small peptide targeting ANP32A as a novel strategy for acute myeloid leukemia therapy.
Wang M; Guo H; Zhang X; Wang X; Tao H; Zhang T; Peng M; Zhang M; Huang Z
Transl Oncol; 2022 Jan; 15(1):101245. PubMed ID: 34678588
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4.
Schramedei K; Mörbt N; Pfeifer G; Läuter J; Rosolowski M; Tomm JM; von Bergen M; Horn F; Brocke-Heidrich K
Oncogene; 2011 Jun; 30(26):2975-85. PubMed ID: 21317927
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
[TBL] [Abstract][Full Text] [Related]
7. Behavioral sensitization induced by methamphetamine causes differential alterations in gene expression and histone acetylation of the prefrontal cortex in rats.
Li H; Chen JA; Ding QZ; Lu GY; Wu N; Su RB; Li F; Li J
BMC Neurosci; 2021 Apr; 22(1):24. PubMed ID: 33823794
[TBL] [Abstract][Full Text] [Related]
8. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
9. Sevoflurane inhibits histone acetylation and contributes to cognitive dysfunction by enhancing the expression of ANP32A in aging mice.
Chai G; Wu J; Fang R; Liu Y; Wang X; Wang X; Zhang J; Zhou J; Jiang Z; Yi H; Nie Y; Zhao P; Zhang D
Behav Brain Res; 2022 Aug; 431():113949. PubMed ID: 35659510
[TBL] [Abstract][Full Text] [Related]
10. PCDH17 functions as a common tumor suppressor gene in acute leukemia and its transcriptional downregulation is mediated primarily by aberrant histone acetylation, not DNA methylation.
Thanh Nha Uyen L; Amano Y; Al-Kzayer LFY; Kubota N; Kobayashi J; Nakazawa Y; Koike K; Sakashita K
Int J Hematol; 2020 Mar; 111(3):451-462. PubMed ID: 31865541
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Histone Acetylation by ANP32A Induces Memory Deficits.
Chai GS; Feng Q; Ma RH; Qian XH; Luo DJ; Wang ZH; Hu Y; Sun DS; Zhang JF; Li X; Li XG; Ke D; Wang JZ; Yang XF; Liu GP
J Alzheimers Dis; 2018; 63(4):1537-1546. PubMed ID: 29782322
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine interaction with acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) regulates PP2A activity and cyclooxygenase (COX)-2 expression in human endothelial cells.
Habrukowich C; Han DK; Le A; Rezaul K; Pan W; Ghosh M; Li Z; Dodge-Kafka K; Jiang X; Bittman R; Hla T
J Biol Chem; 2010 Aug; 285(35):26825-26831. PubMed ID: 20558741
[TBL] [Abstract][Full Text] [Related]
13. MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML.
Sauer T; Arteaga MF; Isken F; Rohde C; Hebestreit K; Mikesch JH; Stelljes M; Cui C; Zhou F; Göllner S; Bäumer N; Köhler G; Krug U; Thiede C; Ehninger G; Edemir B; Schlenke P; Berdel WE; Dugas M; Müller-Tidow C
Exp Hematol; 2015 Sep; 43(9):794-802.e4. PubMed ID: 26072331
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
15. Eya2, a Target Activated by Plzf, Is Critical for
Ono R; Masuya M; Ishii S; Katayama N; Nosaka T
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638
[TBL] [Abstract][Full Text] [Related]
16. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
17. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
18. ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.
Yan W; Bai Z; Wang J; Li X; Chi B; Chen X
Oncol Rep; 2017 Sep; 38(3):1605-1612. PubMed ID: 28731192
[TBL] [Abstract][Full Text] [Related]
19. Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate.
Xiao L; Huang Y; Zhen R; Chiao JW; Liu D; Ma X
Acta Haematol; 2010; 123(2):71-6. PubMed ID: 20051681
[TBL] [Abstract][Full Text] [Related]
20. Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness.
Boileau M; Shirinian M; Gayden T; Harutyunyan AS; Chen CCL; Mikael LG; Duncan HM; Neumann AL; Arreba-Tutusaus P; De Jay N; Zeinieh M; Rossokhata K; Zhang Y; Nikbakht H; Mouawad C; Massoud R; Frey F; Nasr R; El Cheikh J; El Sabban M; Kleinman CL; Mahfouz R; Minden MD; Jabado N; Bazarbachi A; Eppert K
Nat Commun; 2019 Jun; 10(1):2891. PubMed ID: 31253791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
